Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.40
Delayed Data
As of Aug 18
 +0.14 / +11.11%
Today’s Change
1.25
Today|||52-Week Range
7.54
-56.10%
Year-to-Date
Institutional investors purchased a net $1.8 million shares of DMPI during the quarter ended March 2017, and now own 14.82% of the total float, a percentage that is typical for companies in the Wholesale Distributors industry.
Mutual fund holders8.03%
Individual stakeholders7.90%
Other institutional6.79%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2017FRANKLIN ADVISERS, INC.  Bought 1.1 Million shares of DelMar Pharmaceuticals In...
6/30/2017ACROSPIRE INVESTMENT MANAGEMENT ...  Sold 50.00 shares of DelMar Pharmaceuticals In...

Top 10 Owners of DelMar Pharmaceuticals Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Franklin Advisers, Inc.8.00%1,076,9232,347,692+1,076,923--
Sabby Capital LLC5.71%769,2281,676,917+769,228--
Raymond James Financial Services ...0.96%129,580282,48400.00%
Goldman Sachs & Co. LLC (Private ...0.08%10,93523,838-4,027-26.91%
BMO Asset Management Corp.0.06%8,52418,58200.00%
Tower Research Capital LLC0.00%00-400-100.00%
UBS Securities LLC0.00%00-378-100.00%
Acrospire Investment Management L...0.00%00-50-100.00%

Top 10 Mutual Funds Holding DelMar Pharmaceuticals Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
FTIF SICAV - Biotechnology Discov...5.11%688,1531,500,174+688,153--
Franklin Biotechnology Discovery ...2.89%388,770847,519+388,770--
Fidelity Nasdaq Composite Index F...0.03%4,5009,81000.00%